1. Academic Validation
  2. Identification of a potential DNA methyltransferase (DNMT) inhibitor

Identification of a potential DNA methyltransferase (DNMT) inhibitor

  • J Biomol Struct Dyn. 2024 Jun;42(9):4730-4744. doi: 10.1080/07391102.2023.2233637.
Zainab Jan 1 Wesam S Ahmed 2 Kabir H Biswas 2 Puthen Veettil Jithesh 1
Affiliations

Affiliations

  • 1 Division of Genomics and Translational Biomedicine, College of Health & Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • 2 Division of Biological and Biomedical Sciences, College of Health & Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
Abstract

DNA methyltransferases (DNMTs) play an important role in the epigenetic regulation of gene expression through the methylation of DNA. Since hypermethylation and consequent suppression of tumor suppressor genes are associated with Cancer development and progression, DNA hypomethylating agents (HMAs) such as DNMT inhibitors have been proposed for Cancer therapy. Two nucleoside analogues approved for the treatment of hematological cancers, decitabine and azacytidine, have poor pharmacokinetic properties, and hence there is a critical need for identifying novel HMAs. Virtual screening of a library of ∼40,000 compounds from the ZINC database, followed by molecular docking of 4,000 compounds having potential druggable properties with DNMT1, DNMT3A and DNMT3B were performed. One unique inhibitor (ZINC167686681) was identified that successfully passed through the Lipinski Rule of 5, geometry constraints as well as ADME/Tox filters and having strong binding energy for DNMTs. Further, molecular dynamics simulations of the docked complexes showed detailed structural features critical for its binding with the DNMTs and the stability of their interaction. Our study identified a compound with potential druggable properties and predicted to bind and inhibit DNMTs. Further investigations involving cellular and animal models of ZINC167686681 will help in potentially taking it into clinical trials for the treatment of cancers.Communicated by Ramaswamy H. Sarma.

Keywords

DNA hypomethylating agents; DNA methyltransferases; DNMT inhibitors; cancer therapy; drug discovery; virtual screening.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》